Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    Open Studies | "Urticaria"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urticaria"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation
Condition: Urticaria
Interventions: Dietary Supplement: Vitamin D (4,000 IU/day);   Dietary Supplement: Vitamin D (400 IU/day);   Drug: Omalizumab
2 Recruiting Monitoring Chronic Urticaria Basophil Irritability by Cytometry
Condition: Urticaria
Intervention: Other: Basophil patterns
3 Recruiting High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
Condition: Urticaria
Interventions: Drug: Vitamin D3 (High dose);   Drug: Vitamin D3 (Low dose)
4 Recruiting AWARE - Chronic Urticaria
Condition: Chronic Urticaria
Intervention:
5 Recruiting Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
Condition: Chronic Urticaria
Interventions: Drug: 10 mg Rupatadine on demand;   Drug: 10 mg Rupatadine;   Drug: 20 mg Rupatadine;   Drug: 10 mg Rupatadine on demand (sham updosing to 20 mg)
6 Not yet recruiting Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
Condition: Acute Urticaria
Interventions: Drug: Test Drug (JDP-205);   Drug: Active Control (Diphenhydramine)
7 Not yet recruiting Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria
Condition: Chronic Spontaneous Urticaria
Interventions: Drug: Levocetirizine (as levocetirizine dihydrochloride), 5mg ( then 20 mg) per day . Oral administration.;   Drug: Levocetirizine, (as levocetirizine dihydrochloride) 20 mg ( then 5 mg) per day. Oral administration.
8 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
9 Recruiting Efficacy Study of Canakinumab to Treat Urticaria
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Canakinumab;   Drug: Placebo
10 Recruiting A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients
Condition: Chronic Spontaneous Urticaria
Intervention: Biological: QGE031
11 Recruiting Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria
Condition: Chronic Idiopathic Urticaria
Intervention: Biological: Xolair
12 Recruiting Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
Condition: Urticaria
Interventions: Drug: GSK2646264 0.5% topical cream;   Drug: GSK2646264 1% topical cream;   Drug: Placebo
13 Recruiting Dietary Treatment for Chronic Urticaria
Conditions: Diet Modification;   Chronic Urticaria
Interventions: Other: Treatment group (on low histamine diet);   Other: Well-balanced diet
14 Recruiting Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
Condition: Chronic Spontaneous Urticaria
Interventions: Biological: QGE031;   Biological: Omalizumab;   Other: Placebo
15 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
16 Recruiting Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
Conditions: Allergic Rhinitis;   Non-allergic Rhinitis;   Chronic Urticaria
Intervention:
17 Not yet recruiting Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria
Conditions: Urticaria;   Autoimmune Diseases;   Immune System Diseases;   Skin Diseases
Intervention: Biological: Autologous mesenchymal stem cell
18 Recruiting The Role of the Coagulation Pathways in Recurrent Angioedema
Condition: Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency
Intervention: Other: BLOOD TEST
19 Not yet recruiting Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
Conditions: Urticaria Pigmentosa;   Cutaneous Mastocytosis
Interventions: Other: skin biopsy;   Other: blood draw
20 Recruiting Bococizumab HIV Evaluation (B-HIVE) Study
Conditions: Dyslipidemia;   Cardiovascular Disease
Interventions: Drug: Bococizumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.